BLFS
BIOLIFE SOLUTIONS INC
Key Financials
Operating Income
$-16602000
↓ 132.9%
Gross Profit
$62.1M
↑ 24.0%
Net Income
$-4595000
↑ 77.2%
Revenue
$6.2M
↓ 30.8%
Shareholders' Equity
$371.9M
↑ 6.6%
Total Assets
$405.9M
↑ 1.6%
EPS (Diluted)
$-0.10
↑ 77.3%
Cash & Equivalents
$33.0M
↓ 65.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 5/20/2026 | View on SEC |
| 144 | 5/19/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| SCHEDULE 13G/A | 5/6/2026 | View on SEC |
| 10-K/A | 4/28/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BLFS |
| Company Name | BIOLIFE SOLUTIONS INC |
| CIK | 834365 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4254011400 |